In vitro efficacy of fosfomycin against E. coli and prevalence of MDR and XDR E. coli isolates from UTI Patients

In vitro efficacy of fosfomycin against E. coli and prevalence of MDR and XDR E. coli isolates from UTI Patients

Objective: The efficacy of fosfomycin against ESBL and/or carbapenem-resistant E. coli isolated from urine samples was determined. Methodology: Three hundred fifty (350) urine samples were collected from the patients having UTI visited to the department of Urology, JPMC, Karachi. The CLED agar w...

Full description

Bibliographic Details
Main Authors:	Farhina Nasir, Shahida Kashif, Fakhar Uddin, Muhammad Khalid, Ishtiaque Memon, Talat Samreen
Format:	Article
Language:	English
Published:	Rawalpindi Medical University 2023-04-01
Series:	Journal of Rawalpindi Medical College
Subjects:	Carbapenem resistant, Extensively Drug Resistant, Fosfomycin, Multidrug resistant E. coli, Urinary tract infection
Online Access:	https://journalrmc.com/index.php/JRMC/article/view/2002

Similar Items

Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic <i>Escherichia coli</i> Clinical Isolates
by: Haziel Eleazar Dzib-Baak, et al.
Published: (2022-09-01)

Susceptibility Profile of Nitrofurantoin and Fosfomycin among Carbapenem-resistant Enterobacteriaceae Isolates in UTI from a Tertiary Care Hospital
by: Januki Kalai, et al.
Published: (2023-03-01)

Fosfomycin: Pharmacological, Clinical and Future Perspectives
by: Anneke Corinne Dijkmans, et al.
Published: (2017-10-01)

Fosfomycin resistance mechanisms in Enterobacterales: an increasing threat
by: Vittoria Mattioni Marchetti, et al.
Published: (2023-07-01)

Effect of Glycerol on Fosfomycin Activity against <i>Escherichia coli</i>
by: Miriam Ortiz-Padilla, et al.
Published: (2022-11-01)

Oral fosfomycin for treatment of acute bacterial prostatitis caused by multidrug-resistant Enterobacterales
by: Joaquin Burgos, et al.
Published: (2023-10-01)

Fosfomycin Resistance in Avian Pathogenic Escherichia coli Isolates
by: Wen-jie JIN, et al.
Published: (2012-12-01)

Susceptibility pattern of oral antimicrobials in uncomplicated UTI: Does fosfomycin still stand effective?
by: Priyam Batra, et al.
Published: (2020-01-01)

Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae
by: Peng Liu, et al.
Published: (2020-09-01)

Detection of ESBL/AmpC-Producing and Fosfomycin-Resistant Escherichia coli From Different Sources in Poultry Production in Southern Brazil
by: Luís Eduardo de Souza Gazal, et al.
Published: (2021-01-01)

High incidence of fosfomycin-resistant uropathogenic E. coli among children
by: Wedad M. Abdelraheem, et al.
Published: (2023-07-01)

High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium
by: Yan Guo, et al.
Published: (2017-11-01)

Identification of fosA10, a Novel Plasmid-Mediated Fosfomycin Resistance Gene of Klebsiella pneumoniae Origin, in Escherichia coli
by: Huang Y, et al.
Published: (2020-05-01)

Characterization of fosfomycin resistance and molecular epidemiology among carbapenem-resistant Klebsiella pneumoniae strains from two tertiary hospitals in China
by: Haichen Wang, et al.
Published: (2021-04-01)

Emergence of Fosfomycin Resistance by Plasmid-Mediated <i>fos</i> Genes in Uropathogenic ESBL-Producing <i>E. coli</i> Isolates in Mexico
by: Mario Galindo-Méndez, et al.
Published: (2022-10-01)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
by: Hind Alrowais, et al.
Published: (2015-11-01)

In vitro fosfomycin study on concordance of susceptibility testing methods against ESBL and carbapenem-resistant Enterobacteriaceae
by: Ausilia Aprile, et al.
Published: (2020-12-01)

The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan
by: Sung-Pin Tseng, et al.
Published: (2017-10-01)

Effect of Colistin, Fosfomycin and Meropenem/Vaborbactam on Carbapenem-Resistant Enterobacterales in Egypt: A Cross-Sectional Study
by: Shrief R, et al.
Published: (2022-10-01)

Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance
by: Alexandro Rodríguez-Rojas, et al.
Published: (2013-04-01)

Detection of carbapenem resistant Escherichia coli in cattle and pigs
by: P. R. Sandeep, et al.
Published: (2023-06-01)

Fosfomycin, Applying Known Methods and Remedies to A New Era
by: Viviana Albán M., et al.
Published: (2020-08-01)

Occurrence of plasmid-mediated fosfomycin resistance (fos genes) among Escherichia coli isolates, Portugal
by: Teresa Grilo, et al.
Published: (2023-12-01)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
by: Antonio Sorlozano-Puerto, et al.
Published: (2020-08-01)

Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli
by: Vincent Cattoir, et al.
Published: (2020-10-01)

Fosfomycin versus Nitrofurantoin for the Treatment of Lower UTI in Outpatients
by: Shraddha Sharma, et al.
Published: (2021-05-01)

Fosfomycin activity in vitro against Escherichia coli strains isolated from urine specimens
by: Zdzieblo Magdalena, et al.
Published: (2023-12-01)

Resensitization of Fosfomycin-Resistant <i>Escherichia coli</i> Using the CRISPR System
by: Haniel Siqueira Mortagua Walflor, et al.
Published: (2022-08-01)

Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus
by: Li Y, et al.
Published: (2022-08-01)

Effective Treatment for Uncomplicated Urinary Tract Infections with Oral Fosfomycin, Single Center Four Year Retrospective Study
by: Miroslav Fajfr, et al.
Published: (2020-08-01)

Structural Studies of <i>Klebsiella pneumoniae</i> Fosfomycin-Resistance Protein and Its Application for the Development of an Optical Biosensor for Fosfomycin Determination
by: Christina Varotsou, et al.
Published: (2023-12-01)

Comparative effectiveness and mortality of colistin monotherapy versus colistin-fosfomycin combination therapy for the treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections: A propensity score analysis
by: Wasan Katip, et al.
Published: (2024-05-01)

Distribution of ExPEC Virulence Factors, blaCTX-M, fosA3, and mcr-1 in Escherichia coli Isolated From Commercialized Chicken Carcasses
by: Paula Signolfi Cyoia, et al.
Published: (2019-01-01)

Inactivation of ackA and pta Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in Escherichia coli
by: Hidetada Hirakawa, et al.
Published: (2023-06-01)

In vitro fosfomycin activity in vancomycin-resistant Enterococcus faecalis
by: Silvana Superti, et al.

Prevalence of fosfomycin resistance and gene mutations in clinical isolates of methicillin-resistant Staphylococcus aureus
by: Yi-Chien Lee, et al.
Published: (2020-08-01)

Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France
by: Yahia Benzerara, et al.
Published: (2017-09-01)

Fosfomycin, a therapeutic option for infections produced by multiple drug-resistant Enterobacteriaceae
by: Fatemeh Yeganeh Sefidan, et al.
Published: (2016-07-01)

The Dissemination of Multidrug Resistance (MDR) and Extensively Drug Resistant (XDR) among Uropathogenic E. coli (UPEC) Isolates from Urinary Tract Infection Patients in Babylon Province, Iraq
by: Al-Hasnawy et al.
Published: (2019-12-01)

Molecular Epidemiology of Fosfomycin Resistant <i>E. coli</i> from a Pigeon Farm in China
by: Lu Han, et al.
Published: (2021-06-01)